Early diagnosis of Alzheimer's disease: is MCI too late?

The field of aging and dementia research is advancing rapidly toward the stage of earlier identification of clinical symptoms. Ultimately, clinicians would like to be able to identify individuals who are asymptomatic but at risk for developing dementia. In the interim, the construct of mild cognitive impairment (MCI) has come to represent an intermediate clinical state between the cognitive changes of aging and the very earliest features of Alzheimer's disease. A great deal of research has been generated in the past several years on MCI, and epidemiologic studies are characterizing its frequency in the general population. There are predictors of a more rapid progression from MCI to Alzheimer's disease, and these studies are suggesting techniques for altering future clinical trials. The neuropathology of MCI is intermediate between the neuropathologic changes of aging and fully developed Alzheimer's disease. The breadth of research in MCI is expanding and will be reviewed.

[1]  Nick C Fox,et al.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.

[2]  R. Petersen,et al.  Mild cognitive impairment , 2006, The Lancet.

[3]  D. Bennett,et al.  Mild cognitive impairment , 2006, Neurology.

[4]  H. Amièva,et al.  Incidence and outcome of mild cognitive impairment in a population-based prospective cohort , 2002, Neurology.

[5]  E. Reiman,et al.  CIND AND MCI IN THE ITALIAN ELDERLY: FREQUENCY, VASCULAR RISK FACTORS, PROGRESSION TO DEMENTIA , 2007, Neurology.

[6]  Sheryl Zimmerman,et al.  The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. , 2002, Annual review of public health.

[7]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[8]  V. Pankratz,et al.  The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.

[9]  E. Tangalos,et al.  Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.

[10]  A. Hazra,et al.  An epidemiologic study of mild cognitive impairment in Kolkata, India , 2007, Neurology.

[11]  K. Ritchie Mild cognitive impairment: an epidemiological perspective , 2004, Dialogues in clinical neuroscience.

[12]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[13]  J. Price,et al.  Very mild Alzheimer's disease , 1991, Neurology.

[14]  C. Jack,et al.  Atrophy rates accelerate in amnestic mild cognitive impairment , 2008, Neurology.

[15]  E. Tangalos,et al.  Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. , 2006, Archives of neurology.

[16]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[17]  R. Petersen Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[18]  K. Blennow,et al.  Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study , 2006, The Lancet Neurology.

[19]  C. Jack,et al.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.

[20]  W. Krampla,et al.  Conversion from subtypes of mild cognitive impairment to Alzheimer dementia , 2007, Neurology.

[21]  Cees Jonker,et al.  Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.

[22]  Christopher Clark,et al.  Disease-modifying therapies for Alzheimer disease , 2007, Neurology.

[23]  John C Morris,et al.  Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. , 2006, Archives of neurology.

[24]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .